fingolimod hydrochloride has been researched along with phenanthrenes in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (phenanthrenes) | Trials (phenanthrenes) | Recent Studies (post-2010) (phenanthrenes) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 7,618 | 110 | 3,211 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jadidi-Niaragh, F; Mirshafiey, A | 1 |
| Chang, WT; Liu, PY; Wu, SN | 1 |
1 review(s) available for fingolimod hydrochloride and phenanthrenes
| Article | Year |
|---|---|
Therapeutic approach to multiple sclerosis by novel oral drug.
Topics: Administration, Oral; Cladribine; Crotonates; Diterpenes; Epoxy Compounds; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Multiple Sclerosis; Nitriles; Patents as Topic; Phenanthrenes; Propylene Glycols; Quinolones; Sphingosine; Toluidines | 2011 |
1 other study(ies) available for fingolimod hydrochloride and phenanthrenes
| Article | Year |
|---|---|
Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K
Topics: Animals; Delayed Rectifier Potassium Channels; Fingolimod Hydrochloride; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; Jurkat Cells; Kinetics; Mice; Neurons; Phenanthrenes; Sphingosine-1-Phosphate Receptors; T-Lymphocytes | 2020 |